Rebyota Generic Name & Formulations
Prevention of recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for recurrent CDI.
Limitations of Use
Not for treatment of CDI.
Rebyota Dosage and Administration
For rectal use only. Empty bladder and bowel before administration. Give a single dose (150mL) 24–72hrs after the last dose of antibiotics for CDI.
<18yrs: not established.
Rebyota Boxed Warnings
Manufactured from human fecal matter. Risk of transmissible infectious agents. Potential presence of food allergens. Acute allergic reactions. Have appropriate medical treatment immediately available.
Avoid any oral antibiotic therapy for up to 8 weeks after Rebyota administration.
Rebyota Adverse Reactions
Abdominal pain, diarrhea, abdominal distention, flatulence, nausea.
Rebyota Clinical Trials
Rebyota Patient Counseling